L-去甲肾上腺素酒石酸氢盐水合物 | 339091-66-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: L-去甲肾上腺素酒石酸氢盐水合物
• 中文别名: Α-(氨基甲基)-3,4-二羟基苄醇L-酒石酸氢盐
• 英文名称: (-)-Noradrenaline bitartrate
• 英文别名: 4-(2-amino-1-hydroxyethyl)benzene-1,2-diol;2,3-dihydroxybutanedioic acid;hydrate
• CAS: 339091-66-6；34888-32-9
• 化学式: C12H19NO10
• 分子量: 337.28
• InChiKey: LNBCGLZYLJMGKP-UHFFFAOYSA-N

物化性质

• 稳定性/保质期：
  在常温常压下稳定，应避免与强氧化剂和酸碱直接接触。

计算性质

• 辛醇/水分配系数(LogP)：
  -4.91
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  207
• 氢给体数：
  8
• 氢受体数：
  10

文献信息

• PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION
  申请人：BAXTER INTERNATIONAL INC.

  公开号：US20210275470A1

  公开（公告）日：2021-09-09

  A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.
• [EN] PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION<br/>[FR] SYSTÈME DE RÉCIPIENT SCELLÉ CONDITIONNÉ DE STOCKAGE STABLE DE FORMULATION PHARMACEUTIQUE SENSIBLE À L'OXYGÈNE
  申请人：BAXTER INT

  公开号：WO2021178946A1

  公开（公告）日：2021-09-10

  A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.

表征谱图